Internal tandem duplication of the FLT3 gene confers poor overall survival in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline-based chemotherapy: an International Consortium on Acute Promyelocytic Leukemia study-Reference-Cited by-同舟云学术

Internal tandem duplication of the FLT3 gene confers poor overall survival in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline-based chemotherapy: an International Consortium on Acute Promyelocytic Leukemia study

Published:2014-07-02 Issue:12 Volume:93 Page:2001-2010
ISSN:0939-5555
Container-title:Annals of Hematology
language:en
Short-container-title:Ann Hematol

Author:

Lucena-Araujo Antonio R.,Kim Haesook T.,Jacomo Rafael H.,Melo Raul A.,Bittencourt Rosane,Pasquini Ricardo,Pagnano Katia,Fagundes Evandro M.,Chauffaille Maria de Lourdes,Chiattone Carlos S.,Lima Ana Silvia,Ruiz-Argüelles Guillermo,Undurraga Maria Soledad,Martinez Lem,Kwaan Hau C.,Gallagher Robert,Niemeyer Charlotte M.,Schrier Stanley L.,Tallman Martin S.,Grimwade David,Ganser Arnold,Berliner Nancy,Ribeiro Raul C.,Lo-Coco Francesco,Löwenberg Bob,Sanz Miguel A.,Rego Eduardo M.

Publisher

Springer Science and Business Media LLC

Subject

Hematology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00277-014-2142-9.pdf

Reference55 articles.

1. Frohling S, Schlenk RF, Breitruck J, Benner A, Kreitmeier S, Tobis K et al (2002) Prognostic significance of activating FLT3 mutations in younger adults (16 to 60 years) with acute myeloid leukemia and normal cytogenetics: a study of the AML Study Group Ulm. Blood 100:4372–4380

2. Schlenk RF, Dohner K, Krauter J, Frohling S, Corbacioglu A, Bullinger L et al (2008) Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia. N Engl J Med 358:1909–1918

3. Thiede C, Steudel C, Mohr B, Schaich M, Schakel U, Platzbecker U et al (2002) Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosis. Blood 99:4326–4335

4. Chillon MC, Fernandez C, Garcia-Sanz R, Balanzategui A, Ramos F, Fernandez-Calvo J et al (2004) FLT3-activating mutations are associated with poor prognostic features in AML at diagnosis but they are not an independent prognostic factor. Hematol J 5:239–246

5. Kainz B, Heintel D, Marculescu R, Schwarzinger I, Sperr W, Le T et al (2002) Variable prognostic value of FLT3 internal tandem duplications in patients with de novo AML and a normal karyotype, t(15;17), t(8;21) or inv(16). Hematol J 3:283–289

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cytogenetics and genomics of acute myeloid leukemia;Best Practice & Research Clinical Haematology;2024-03

2. Risk factors and remaining challenges in the treatment of acute promyelocytic leukemia;International Journal of Hematology;2024-02-22

3. Effective treatment with Gilteritinib-based regimens for FLT3-mutant extramedullary relapse in acute promyelocytic leukemia;Hematology;2023-12-14

4. Acute Promyelocytic Leukemia with Rare Genetic Aberrations: A Report of Three Cases;Genes;2022-12-23

5. Myeloid sarcoma mimicking suprasellar meningioma in acute promyelocytic leukaemia;Pathology;2022-12